v3.26.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK BASED COMPENSATION

The following table summarizes stock-based compensation (in thousands):

 

           
   For the three months ended March 31, 
   2026   2025 
         
Research and development  $223   $670 
Selling, general and administrative   2,734    2,031 
Total stock-based compensation expense  $2,957   $2,701 
SCHEDULE OF STOCK OPTION ACTIVITY

The following table summarizes stock option activity during the three months ended March 31, 2026.

 

  

Number of

Options

  

Weighted

Average

Exercise Price

  

Weighted

Average

Remaining

Contractual

Term (years)

  

Aggregate

Intrinsic

Value

(in thousands)

 
                 
Outstanding at December 31, 2025   176,019   $38.72    4.85   $         5 
Granted      $       $ 
Cancelled/forfeited   (1,199)  $36.67       $ 
Exercised      $       $ 
Outstanding at March 31, 2026   174,820   $38.74    4.53   $2 
Exercisable   174,620   $38.77    4.53   $2 
Unvested   200   $4.00    6.20   $ 
SCHEDULE OF RESTRICTED STOCK AWARD ACTIVITY

The following table summarizes restricted stock award activity during the three months ended March 31, 2026:

 

  

Number of

Awards

  

Weighted Average

Grant Date Fair

Value Per Unit

 
         
Outstanding at December 31, 2025   4,180,981   $        4.96 
Granted   2,044,890   $5.29 
Cancelled/forfeited   (221,922)  $5.06 
Vested   (913,224)  $5.26 
Outstanding at March 31, 2026   5,090,725   $5.03